2022年3期
刊物介紹
Drug Combination Therapy（DCT）專注于藥物聯(lián)合治療疾病的最新基礎(chǔ)及臨床研究進(jìn)展，包括增效、解毒、配伍禁忌等，以期為臨床使用提供指導(dǎo)。主要包括3個(gè)方面：中藥聯(lián)合（旨在解讀傳統(tǒng)中藥復(fù)方配伍的內(nèi)在機(jī)制）、西藥聯(lián)合（比如腫瘤聯(lián)合治療、嚴(yán)重感染抗生素聯(lián)合治療、代謝性疾病的聯(lián)合用藥等）以及中西藥物聯(lián)合。下設(shè)述評(píng)、綜述、臨床研究、基礎(chǔ)研究、個(gè)案報(bào)道等欄目。
Drug Combination Therapy
Article
- Mechanism of Liangxue Huayu decoction in treatment of age-related macular degeneration based on network pharmacology and clinical validation
- Exploring the mechanism of action of Danggui Shaoyao San in the treatment of polycystic ovary syndrome based on integrated pharmacology and molecular docking
- Clinical efficacy of Qingre Quzhuo capsule in the treatment of non-alcoholic fatty liver disease
- Retraction: Mechanism of Magnoliae Flos and Xanthii Fructus herb pair in treatment of allergic rhinitis based on network pharmacology.Drug Comb Ther.2022;4(2):9.doi:10.53388/DCT2022009